Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biopsy-driven genomic signature for prostate cancer prognosis

Biopsy-driven genomic signature for prostate cancer prognosis

US Patent 10745760 · Granted Aug 18, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer risk based on tumour clonality2025
Cancer risk based on tumour clonality2025
Gene signature of residual risk following endocrine treatment in early breast ca2023
Mitochondrial DNA prostate cancer marker and related systems and methods2022
Mitochondrial DNA prostate cancer marker and related systems and methods2022
Methods and devices for predicting anthracycline treatment efficacy2022
Materials and methods for prognosing lung cancer survival2011